Complejo Hospitalario Universitario de Lugo
Centro asistencial
McMaster University
Hamilton, CanadáPublicaciones en colaboración con investigadores/as de McMaster University (10)
2024
-
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383
2022
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1667-1684
2021
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
Exacerbations of severe asthma while on anti–il-5 biologics
Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 307-316
2019
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
2015
-
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580